Bryan Garnier - CARBIOS (ALCRB FP) CARBIOS: Appointment of a new CEO, directly from Michelin’s top management | CORPORATE | EUR60(+60%)

Report

Bryan Garnier

Xavier Regnard

CARBIOS: Appointment of a new CEO, directly from Michelin’s top management | CORPORATE | EUR60(+60%)

CARBIOS - CORPORATE | EUR60(+60%)
Appointment of a new CEO, directly from Michelin’s top management

Mr. Ladent is bringing strong industrial and international background
A profile that fits with Carbios’ growing maturity
Not surprising to see someone from Michelin
Very positive stance confirmed. TP EUR60

08/11/2021 4 EN

Underlying

CARBIOS

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Xavier Regnard

Other Reports on these Companies

Bryan Garnier

CARBIOS: Collaboration with Indorama Ventures to build the first industrial unit | CORPORATE | EUR70 VS. EUR60 (+107%)

CARBIOS - CORPORATE | EUR70 VS. EUR60 (+107%) Collaboration with Indorama Ventures to build the first industrial unit Carbios announced a collaboration with Indorama Ventures for the construction of its first industrial unit (bigger than anticipated). This collaboration is a very good news, not only because it confirms the credibility and potential of Carbios’ technology but also because it could lead to future licensing deals with Indorama, the world’s largest PET producer. We increase our TP from EUR60 to EUR70.

February 24, 2022 February 24, 2022 1 EN

Bryan Garnier

CARBIOS - CORPORATE | EUR60(+51%) Two PET producers shortlisted. Carbios is about to accelerate its industrial development

CARBIOS - CORPORATE | EUR60(+51%) Two PET producers shortlisted. Carbios is about to accelerate its industrial development Entering the final stage of selection First results from the demo plant confirm the potential of the technology Positive newsflow over the coming weeks should revive the stock momentum Very positive stance confirmed. TP EUR60

January 19, 2022 January 19, 2022 1 EN

Bryan Garnier

CARBIOS - CORPORATE | EUR60(+61%) European funding to support the industrial deployment of the enzymatic PET recycling

CARBIOS - CORPORATE | EUR60(+61%) European funding to support the industrial deployment of the enzymatic PET recycling A new grant that confirms the high potential of Carbios’ technology We expect further positive newsflow in the next few weeks/months On track for a first industrial unit by end-2024 Still a lot of upside to capture. Target price confirmed : EUR60

November 26, 2021 November 26, 2021 4 EN

ONWARD: from brainGPT to ARC-BCI – fireside chat with the founders

Yesterday, we hosted an exclusive fireside chat at our Paris HQ with ONWARD's co-founders, Dr. Grégoire Courtine and Dr. Jocelyne Bloch, accompanied by institutional investors, to learn about the professional endeavours that led them to jump from researchers to entrepreneurs, with a special deep-di

April 25, 2025 April 25, 2025 1 EN

Mahaut Arnaud ... (+3)

Mahaut Arnaud
Paul de Froment
Thomas Mordelle

Avantium: joint-development progress in textiles

Yesterday, Avantium announced the successful development of a PEF-based spacer fabric in collaboration with partners Auping, Muller Textiles, Antex and Monosuisse. This breathable, cushioning 3D material marks a step forward for this partnership, ongoing since 2024, aiming to create PEF-based yarns

April 25, 2025 April 25, 2025 1 EN

Oscar Haffen Lamm

Oscar Haffen Lamm

Egetis: Article highlights Emcitate's broad efficacy in MCT8 deficiency

A recent publication in Nature Communications (Groeneweg, van Geest et al. 2025) highlights the broad therapeutic applicability of Emcitate across the heterogeneity of the MCT8 deficient target group and supporting its uniform treatment eligibility across a genetically diverse patient population. I

April 25, 2025 April 25, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

CARBIOS: Appointment of a new CEO, directly from Michelin’s top management | CORPORATE | EUR60(+60%)

CARBIOS: Collaboration with Indorama Ventures to build the first industrial unit | CORPORATE | EUR70 VS. EUR60 (+107%)

CARBIOS - CORPORATE | EUR60(+51%) Two PET producers shortlisted. Carbios is about to accelerate its industrial development

CARBIOS - CORPORATE | EUR60(+61%) European funding to support the industrial deployment of the enzymatic PET recycling

ONWARD: from brainGPT to ARC-BCI – fireside chat with the founders

Avantium: joint-development progress in textiles

Egetis: Article highlights Emcitate's broad efficacy in MCT8 deficiency

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe